Gastroenterology
Volume 136, Issue 1 , Pages 9-16, January 2009

The Accelerating Pace of HCV Research: A Summary of the 15th International Symposium on Hepatitis C Virus and Related Viruses

  • Robert E. Lanford

      Affiliations

    • Southwest Foundation for Biomedical Research, San Antonio, Texas
    • ,
  • Matthew J. Evans

      Affiliations

    • Department of Microbiology, Mount Sinai School of Medicine, New York, New York
    • ,
  • Volker Lohmann

      Affiliations

    • Department of Molecular Virology, University of Heidelberg, Heidelberg, Germany
    • ,
  • Brett Lindenbach

      Affiliations

    • Section of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut
    • ,
  • Michael Gale Jr

      Affiliations

    • Department of Immunology, University of Washington, Seattle, Washington
    • ,
  • Barbara Rehermann

      Affiliations

    • Immunology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland
    • ,
  • Kyong–Mi Chang

      Affiliations

    • University of Pennsylvania and Philadelphia VA Medical Center, Philadelphia, Pennsylvania
    • ,
  • Stanley M. Lemon

      Affiliations

    • Institute for Human Infections & Immunity, University of Texas Medical Branch, Galveston, Texas
    • Corresponding Author InformationAddress requests for reprints to: Stanley M. Lemon, MD, Institute of Human Infections & Immunity, 6.200 Galveston National Laboratory, University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555-0610. fax: (409) 747-6514

published online 20 November 2008.

Abbreviations used in this paper: CLDN1, claudin-1, HCVcc, cell culture-infectious virus, HCVpp, hepatitis C virus–pseudotyped viral particles, IFN, interferon, ISG, interferon-stimulated gene, OCLN, occludin, PD-1, programmed death-1, TLR, Toll-like receptor

No abstract is available. To read the body of this article, please view the Full Text online.

 

 The authors disclose the following: Supported in part by National Institute of Allergy and Infectious Diseases grants U19-AI040035 (to S.M.L., R.E.L., M.G.), R01-AI060389 (to M.G.), NIKKD, NIH intramural research program (BR) R01-AI47519 (to K.-M.C.), and K99-AI077800 (to M.J.E.), National Cancer Institute grant K01-CA107092 (to B.L.), and Deutsche Forschungsgemeinschaft grant Lo 1556/1-1 (to V.L.).

 S.M.L. serves as a consultant to Genelabs Technologies, Abbott Laboratories, GlaxoSmithKline, and Pfizer, and R.E.L. is a consultant for Abbott Laboratories. The remaining authors disclose no conflicts of interest.

PII: S0016-5085(08)02048-9

doi:10.1053/j.gastro.2008.11.019

Gastroenterology
Volume 136, Issue 1 , Pages 9-16, January 2009